2 London Mempool companies backed by OrbiMed

Rank =208 of 430 on the investor leaderboard. No source we have says it led a round in any of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Health22 Health companies

Portfolio on the map (2)

Verdiva Bio$411M
Clinical-stage biotech developing next-generation oral and injectable medicines for obesity and cardiometabolic disease.
Health · Obesity Therapeutics · Fastest growing
source: biospace.com
CHARM Therapeutics$150M+
AI-driven drug discovery company developing a next-generation menin inhibitor for acute myeloid leukaemia, based in London and Cambridge.
Health · AI Drug Discovery · Fastest growing
source: uk.finance.yahoo.com

We list OrbiMed on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count